Century Therapeutics, Inc. (IPSC)
2.08
-0.03
(-1.42%)
USD |
NASDAQ |
Sep 03, 15:41
Century Therapeutics Research and Development Expense (Annual) : 82.57M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 82.57M |
| December 31, 2024 | 107.24M |
| December 31, 2023 | 92.71M |
| December 31, 2022 | 97.17M |
| Date | Value |
|---|---|
| December 31, 2021 | 75.65M |
| December 31, 2020 | 39.68M |
| December 31, 2019 | 14.27M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tenax Therapeutics, Inc. | 32.67M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 3.286M |
| Absci Corp. | 80.72M |
| Celularity, Inc. | 9.222M |